Axon Therapies
New York
About Axon Therapies
Axon Therapies developed the SAVM procedure. Their novel approach to modulating the body’s sympathetic nervous system to restore balance in the circulatory system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $35.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2025)
- Website: axontherapies.com
Industries & Categories
Health Care, Neuroscience, Travel
Social Profiles
Canonical: https://fsome.com/organization/axon-therapies-25877 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.